Glycerol Phenylbutyrate Liquid
Product Images NDC 59651-988

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Glycerol Phenylbutyrate (NDC 59651-988). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig (Glycerol Fig1)

Fig (Glycerol Fig1)
This text appears to be a diagram or list showing the metabolic pathway involving Glycerol Phenylbutyrate and its conversion into Phenylacetylglutamine, leading to their excretion in urine. The diagram or list includes processes like ester hydrolysis, a-Ketoglutarate synthesis, beta-oxidation, and involvement of pancreatic lipases. The text outlines the biochemical reactions and components of the pathway but does not provide detailed explanations.*
FDA Label Image

Figure (Glycerol Fig2)

FDA Label Image

Figure (Glycerol Fig3)

FDA Label Image

Figure (Glycerol Fig4)

FDA Label Image

Figure (Glycerol Fig5)

FDA Label Image

Figure (Glycerol Fig6)

Figure (Glycerol Fig6)
Store at 20° to 25°C (68° to 77°F). Aurobindo Pharma USA, Inc. distributed this medication. Store with excursions allowed to 15° to 30°C (59° to 86°F). Once opened, discard any unused portion after 28 days. This oral medication contains 1.1 grams per mL and is for oral use only. Make sure to dispense the Medication Guide available at www.aurobindousa.com/medication-guides to each patient. The packaging will include the GTIN, Serial Number, Expiry Date, and LOT in human coding area alongside a 2D code for easy scanning.*
FDA Label Image

Figure (Glycerol Fig7)

Figure (Glycerol Fig7)
This text appears to be a label for a medication. The product is described as an oral liquid solution containing glycerol and phenylbutyrate. It provides instructions on storage conditions and dosage information for oral use. The label also includes details about its distribution and the pharmaceutical company responsible for its production.*
FDA Label Image

Str (Glycerol Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.